Home > Medical Reference > Complementary Medicine

Alitretinoin


Pronunciation

(a li TRET i noyn)


U.S. Brand Names

Panretin®


Generic Available

No


Canadian Brand Names

Panretin®


Use

Orphan drug: Topical treatment of cutaneous lesions in AIDS-related Kaposi's sarcoma


Use - Unlabeled/Investigational

Cutaneous T-cell lymphomas


Pregnancy Risk Factor

D


Pregnancy Implications

Potentially teratogenic and/or embryotoxic; limb, craniofacial, or skeletal defects have been observed in animal models. If used during pregnancy or if the patient becomes pregnant while using alitretinoin, the woman should be advised of potential harm to the fetus. Women of childbearing potential should avoid becoming pregnant.


Lactation

Excretion in breast milk unknown/not recommended


Contraindications

Hypersensitivity to alitretinoin, other retinoids, or any component of the formulation; pregnancy


Warnings/Precautions

May cause fetal harm if absorbed by a woman who is pregnant. May be photosensitizing (based on experience with other retinoids); minimize sun or other UV exposure of treated areas. Do not use concurrently with topical products containing DEET (increased toxicity may result). Safety in pediatric patients or geriatric patients has not been established.


Adverse Reactions

>10%:

Central nervous system: Pain (0% to 34%)

Dermatologic: Rash (25% to 77%), pruritus (8% to 11%)

Neuromuscular & skeletal: Paresthesia (3% to 22%)

5% to 10%:

Cardiovascular: Edema (3% to 8%)

Dermatologic: Exfoliative dermatitis (3% to 9%), skin disorder (0% to 8%)


Overdosage/Toxicology

There has been no experience with human overdosage of alitretinoin, and overdose is unlikely following topical application. Treatment is symptomatic and supportive.


Drug Interactions

Increased toxicity of DEET may occur if products containing this compound are used concurrently with alitretinoin. Due to limited absorption after topical application, interaction with systemic medications is unlikely.


Stability

Store at room temperature


Mechanism of Action

Binds to retinoid receptors to inhibit growth of Kaposi's sarcoma


Pharmacodynamics/Kinetics

Absorption: Not extensive


Dosage

Topical: Apply gel twice daily to cutaneous Kaposi's sarcoma or T-cell lymphoma (unlabeled use) lesions


Administration

Do not use occlusive dressings.


Patient Education

For external use only. Use exactly as directed; do not overuse. Avoid use of any product such as insect repellents which contain DEET (check with your pharmacist). Wear protective clothing and/or avoid exposure to direct sun or sunlamps. Wash hands thoroughly before applying. Avoid applying skin products that contain alcohol or harsh chemicals during treatment. Do not apply occlusive dressings. Stop treatment and inform prescriber if rash, skin irritation, redness, scaling, or excessive dryness appears. Pregnancy/breast-feeding precautions: Do not get pregnant while taking this medication. Consult prescriber for appropriate contraceptive measures. Breast-feeding is not recommended.


Dental Health: Effects on Dental Treatment

No significant effects or complications reported


Dental Health: Vasoconstrictor/Local Anesthetic Precautions

No information available to require special precautions


Mental Health: Effects on Mental Status

Pain is common


Mental Health: Effects on Psychiatric Treatment

May be photosensitizing; caution with psychotropics


Oncology: Emetic Potential

Very low (<10%)


Dosage Forms

Gel: 0.1% (60 g tube)


International Brand Names

Panretin™ (CA); Panretin® (FR)


A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process . A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com